Martha J. Demski
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
35,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Martha J. Demski
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
35,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Martha J. Demski
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
50,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Martha J. Demski
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
60,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Martha J. Demski
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
60,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Martha J. Demski
|
Director |
Sale or transfer of securities back to the company at price $ 8.55 per share. |
21 Apr 2025 |
72,055 |
0
(0%)
|
0%
|
8.5 |
616,070
|
Common Stock |
Martha J. Demski
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
9,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Martha J. Demski
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
9,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Martha J. Demski
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
21,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Martha J. Demski
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
21,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Martha J. Demski
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
21,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Michael A. Alrutz
|
SVP AND GENERAL COUNSEL |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
45,750 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Michael A. Alrutz
|
SVP AND GENERAL COUNSEL |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
135,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Michael A. Alrutz
|
SVP AND GENERAL COUNSEL |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
176,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Michael A. Alrutz
|
SVP AND GENERAL COUNSEL |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
165,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Michael A. Alrutz
|
SVP AND GENERAL COUNSEL |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
170,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Michael A. Alrutz
|
SVP AND GENERAL COUNSEL |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
200,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Michael A. Alrutz
|
SVP AND GENERAL COUNSEL |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
128,550 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Michael A. Alrutz
|
SVP AND GENERAL COUNSEL |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
131,250 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Michael A. Alrutz
|
SVP AND GENERAL COUNSEL |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
250,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Michael A. Alrutz
|
SVP AND GENERAL COUNSEL |
Sale or transfer of securities back to the company at price $ 8.55 per share. |
21 Apr 2025 |
216,689 |
0
(0%)
|
0%
|
8.6 |
1,852,691
|
Common Stock |
Michael A. Alrutz
|
SVP AND GENERAL COUNSEL |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
178,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Michael A. Alrutz
|
SVP AND GENERAL COUNSEL |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
15,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Fred A. Middleton
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
60,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Fred A. Middleton
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
60,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Fred A. Middleton
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
50,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Fred A. Middleton
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
35,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Fred A. Middleton
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
35,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Fred A. Middleton
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
21,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Fred A. Middleton
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
21,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Fred A. Middleton
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
42,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Fred A. Middleton
|
Director |
Sale or transfer of securities back to the company at price $ 8.55 per share. |
21 Apr 2025 |
207,523 |
0
(0%)
|
0%
|
8.6 |
1,774,322
|
Common Stock |
Fred A. Middleton
|
Director |
Sale or transfer of securities back to the company at price $ 8.55 per share. |
21 Apr 2025 |
531,861 |
0
(0%)
|
0%
|
8.6 |
4,547,412
|
Common Stock |
Fred A. Middleton
|
Director |
Sale or transfer of securities back to the company at price $ 8.55 per share. |
21 Apr 2025 |
2,776,093 |
0
(0%)
|
4%
|
8.5 |
23,735,595
|
Common Stock |
Fred A. Middleton
|
Director |
Sale or transfer of securities back to the company at price $ 8.55 per share. |
21 Apr 2025 |
60,000 |
0
(0%)
|
0%
|
8.6 |
513,000
|
Common Stock |
Fred A. Middleton
|
Director |
Sale or transfer of securities back to the company at price $ 8.55 per share. |
21 Apr 2025 |
40,000 |
0
(0%)
|
0%
|
8.6 |
342,000
|
Common Stock |
Marc D. Kozin
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
60,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Marc D. Kozin
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
100,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Michael A. Sherman
|
Director, Chief Executive Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
557,050 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Michael A. Sherman
|
Director, Chief Executive Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
60,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Michael A. Sherman
|
Director, Chief Executive Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
875,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Michael A. Sherman
|
Director, Chief Executive Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
700,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Michael A. Sherman
|
Director, Chief Executive Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
632,500 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Michael A. Sherman
|
Director, Chief Executive Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
1,150,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Michael A. Sherman
|
Director, Chief Executive Officer |
Sale or transfer of securities back to the company at price $ 8.55 per share. |
21 Apr 2025 |
233,413 |
0
(0%)
|
0%
|
8.5 |
1,995,681
|
Common Stock |
Michael A. Sherman
|
Director, Chief Executive Officer |
Sale or transfer of securities back to the company at price $ 8.55 per share. |
21 Apr 2025 |
102,995 |
0
(0%)
|
0%
|
8.5 |
880,607
|
Common Stock |
Michael A. Sherman
|
Director, Chief Executive Officer |
Sale or transfer of securities back to the company at price $ 8.55 per share. |
21 Apr 2025 |
87,000 |
0
(0%)
|
0%
|
8.6 |
743,850
|
Common Stock |
Pratik S. Multani
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
35,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Pratik S. Multani
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
35,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Pratik S. Multani
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
50,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Pratik S. Multani
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
60,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Pratik S. Multani
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
60,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Pratik S. Multani
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
60,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Robert J. Meyer
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
60,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Robert J. Meyer
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
50,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Robert J. Meyer
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
35,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Robert J. Meyer
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
21,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Robert J. Meyer
|
Director |
Sale or transfer of securities back to the company at price $ 8.55 per share. |
21 Apr 2025 |
35,150 |
0
(0%)
|
0%
|
8.6 |
300,533
|
Common Stock |
Robert J. Meyer
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
42,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Robert J. Meyer
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
21,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Robert J. Meyer
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
35,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Robert J. Meyer
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
60,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Michael T. Andriole
|
Director, PRESIDENT AND CEO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
300,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Michael T. Andriole
|
Director, PRESIDENT AND CEO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
192,825 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Michael T. Andriole
|
Director, PRESIDENT AND CEO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
150,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Michael T. Andriole
|
Director, PRESIDENT AND CEO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
502,500 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Michael T. Andriole
|
Director, PRESIDENT AND CEO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
900,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Michael T. Andriole
|
Director, PRESIDENT AND CEO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
250,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Michael T. Andriole
|
Director, PRESIDENT AND CEO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
192,500 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Michael T. Andriole
|
Director, PRESIDENT AND CEO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
450,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Michael T. Andriole
|
Director, PRESIDENT AND CEO |
Sale or transfer of securities back to the company at price $ 8.55 per share. |
21 Apr 2025 |
630,828 |
0
(0%)
|
1%
|
8.5 |
5,393,579
|
Common Stock |
Thomas J. Riga
|
COO and CCO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
325,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Thomas J. Riga
|
COO and CCO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
800,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Thomas J. Riga
|
COO and CCO |
Sale or transfer of securities back to the company at price $ 8.55 per share. |
21 Apr 2025 |
60,828 |
0
(0%)
|
0%
|
8.5 |
520,079
|
Common Stock |
David Jakeman
|
VP OF FINANCE AND ACCOUNTING |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
64,500 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
David Jakeman
|
VP OF FINANCE AND ACCOUNTING |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
18,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
David Jakeman
|
VP OF FINANCE AND ACCOUNTING |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
24,950 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
David Jakeman
|
VP OF FINANCE AND ACCOUNTING |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
1,500 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
David Jakeman
|
VP OF FINANCE AND ACCOUNTING |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
29,900 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
David Jakeman
|
VP OF FINANCE AND ACCOUNTING |
Sale or transfer of securities back to the company at price $ 8.55 per share. |
21 Apr 2025 |
156,209 |
0
(0%)
|
0%
|
8.6 |
1,335,587
|
Common Stock |
David Jakeman
|
VP OF FINANCE AND ACCOUNTING |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
10,150 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
David Jakeman
|
VP OF FINANCE AND ACCOUNTING |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
10,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
David Jakeman
|
VP OF FINANCE AND ACCOUNTING |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
7,200 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
David Jakeman
|
VP OF FINANCE AND ACCOUNTING |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
1,250 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
David Jakeman
|
VP OF FINANCE AND ACCOUNTING |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
9,360 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
David Jakeman
|
VP OF FINANCE AND ACCOUNTING |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
10,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
David Jakeman
|
VP OF FINANCE AND ACCOUNTING |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
30,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
David Jakeman
|
VP OF FINANCE AND ACCOUNTING |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
28,320 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
David Jakeman
|
VP OF FINANCE AND ACCOUNTING |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
1,500 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
David Jakeman
|
VP OF FINANCE AND ACCOUNTING |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
65,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Lisa Lynn Decker
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
100,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Lisa Lynn Decker
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
60,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Allen S. Melemed
|
CHIEF MEDICAL OFFICER |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
190,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Allen S. Melemed
|
CHIEF MEDICAL OFFICER |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
240,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Allen S. Melemed
|
CHIEF MEDICAL OFFICER |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
154,260 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Allen S. Melemed
|
CHIEF MEDICAL OFFICER |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
168,750 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Allen S. Melemed
|
CHIEF MEDICAL OFFICER |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
275,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Allen S. Melemed
|
CHIEF MEDICAL OFFICER |
Sale or transfer of securities back to the company at price $ 8.55 per share. |
21 Apr 2025 |
173,852 |
0
(0%)
|
0%
|
8.6 |
1,486,435
|
Common Stock |
Allen S. Melemed
|
CHIEF MEDICAL OFFICER |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
400,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Victoria Vakiener
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
60,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Victoria Vakiener
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
60,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Victoria Vakiener
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
60,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Victoria Vakiener
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
35,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Victoria Vakiener
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
50,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Michelle LaSpaluto
|
CHIEF FINANCIAL OFFICER |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
1,500 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Michelle LaSpaluto
|
CHIEF FINANCIAL OFFICER |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
18,700 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Michelle LaSpaluto
|
CHIEF FINANCIAL OFFICER |
Sale or transfer of securities back to the company at price $ 8.55 per share. |
21 Apr 2025 |
181,541 |
0
(0%)
|
0%
|
8.6 |
1,552,176
|
Common Stock |
Michelle LaSpaluto
|
CHIEF FINANCIAL OFFICER |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
90,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Michelle LaSpaluto
|
CHIEF FINANCIAL OFFICER |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
150,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Michelle LaSpaluto
|
CHIEF FINANCIAL OFFICER |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
17,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Michelle LaSpaluto
|
CHIEF FINANCIAL OFFICER |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
64,275 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Michelle LaSpaluto
|
CHIEF FINANCIAL OFFICER |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
95,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Michelle LaSpaluto
|
CHIEF FINANCIAL OFFICER |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
250,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Michelle LaSpaluto
|
CHIEF FINANCIAL OFFICER |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
62,067 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Michelle LaSpaluto
|
CHIEF FINANCIAL OFFICER |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
48,438 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Michelle LaSpaluto
|
CHIEF FINANCIAL OFFICER |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
8,098 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Michelle LaSpaluto
|
CHIEF FINANCIAL OFFICER |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
13,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Michelle LaSpaluto
|
CHIEF FINANCIAL OFFICER |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
1,250 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Michelle LaSpaluto
|
CHIEF FINANCIAL OFFICER |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
21 Apr 2025 |
15,000 |
0
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Michael A. Alrutz
|
SVP AND GENERAL COUNSEL |
Sale of securities on an exchange or to another person at price $ 4.52 per share. |
13 Feb 2025 |
1,600 |
213,596
(0%)
|
0%
|
4.5 |
7,226
|
Common Stock |
Michael T. Andriole
|
Director, PRESIDENT AND CEO |
Sale of securities on an exchange or to another person at price $ 4.52 per share. |
13 Feb 2025 |
7,370 |
609,603
(0%)
|
0%
|
4.5 |
33,282
|
Common Stock |
David Jakeman
|
VP OF FINANCE AND ACCOUNTING |
Sale of securities on an exchange or to another person at price $ 4.53 per share. |
13 Feb 2025 |
300 |
148,987
(0%)
|
0%
|
4.5 |
1,360
|
Common Stock |
Allen S. Melemed
|
CHIEF MEDICAL OFFICER |
Sale of securities on an exchange or to another person at price $ 4.50 per share. |
13 Feb 2025 |
3,065 |
152,875
(0%)
|
0%
|
4.5 |
13,799
|
Common Stock |
Michelle LaSpaluto
|
CHIEF FINANCIAL OFFICER |
Sale of securities on an exchange or to another person at price $ 4.51 per share. |
13 Feb 2025 |
2,260 |
172,977
(0%)
|
0%
|
4.5 |
10,196
|
Common Stock |
Michael T. Andriole
|
Director, PRESIDENT AND CEO |
Sale of securities on an exchange or to another person at price $ 4.10 per share. |
30 Jan 2025 |
2,350 |
616,973
(0%)
|
0%
|
4.1 |
9,636
|
Common Stock |
David Jakeman
|
VP OF FINANCE AND ACCOUNTING |
Sale of securities on an exchange or to another person at price $ 4.10 per share. |
30 Jan 2025 |
2,800 |
149,287
(0%)
|
0%
|
4.1 |
11,470
|
Common Stock |
Michelle LaSpaluto
|
CHIEF FINANCIAL OFFICER |
Sale of securities on an exchange or to another person at price $ 4.11 per share. |
30 Jan 2025 |
1,015 |
175,237
(0%)
|
0%
|
4.1 |
4,172
|
Common Stock |
Michael A. Alrutz
|
SVP AND GENERAL COUNSEL |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
07 Jan 2025 |
41,667 |
215,196
(0%)
|
0%
|
|
0
|
Common Stock |
Michael A. Alrutz
|
SVP AND GENERAL COUNSEL |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
07 Jan 2025 |
250,000 |
250,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michael T. Andriole
|
Director, PRESIDENT AND CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
07 Jan 2025 |
150,000 |
619,323
(1%)
|
0%
|
|
0
|
Common Stock |
Michael T. Andriole
|
Director, PRESIDENT AND CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
07 Jan 2025 |
900,000 |
900,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Thomas J. Riga
|
COO and CCO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
07 Jan 2025 |
54,275 |
57,501
(0%)
|
0%
|
|
0
|
Common Stock |
Thomas J. Riga
|
COO and CCO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
07 Jan 2025 |
325,000 |
325,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
David Jakeman
|
VP OF FINANCE AND ACCOUNTING |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
07 Jan 2025 |
65,000 |
65,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
David Jakeman
|
VP OF FINANCE AND ACCOUNTING |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
07 Jan 2025 |
10,855 |
152,087
(0%)
|
0%
|
|
0
|
Common Stock |
Allen S. Melemed
|
CHIEF MEDICAL OFFICER |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
07 Jan 2025 |
45,925 |
155,940
(0%)
|
0%
|
|
0
|
Common Stock |
Allen S. Melemed
|
CHIEF MEDICAL OFFICER |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
07 Jan 2025 |
275,000 |
275,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michelle LaSpaluto
|
CHIEF FINANCIAL OFFICER |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
07 Jan 2025 |
41,667 |
176,252
(0%)
|
0%
|
|
0
|
Common Stock |
Michelle LaSpaluto
|
CHIEF FINANCIAL OFFICER |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
07 Jan 2025 |
250,000 |
250,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Fred A. Middleton
|
Director |
Gift of securities by or to the insider at price $ 0.00 per share. |
28 Oct 2024 |
60,000 |
40,000
(0%)
|
0%
|
|
0
|
Common Stock |
Michael T. Andriole
|
Director, PRESIDENT AND CEO |
Sale of securities on an exchange or to another person at price $ 0.83 per share. |
08 Aug 2024 |
1,285 |
462,453
(0%)
|
0%
|
0.8 |
1,065
|
Common Stock |
Martha J. Demski
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2024 |
60,000 |
60,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Fred A. Middleton
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2024 |
60,000 |
60,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Marc D. Kozin
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2024 |
60,000 |
60,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michael Sherman
|
Director, Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2024 |
60,000 |
60,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Pratik S. Multani
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2024 |
60,000 |
60,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Robert J. Meyer
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2024 |
60,000 |
60,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Lisa Lynn Decker
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2024 |
60,000 |
60,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Victoria Vakiener
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2024 |
60,000 |
60,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Marc D. Kozin
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Mar 2024 |
100,000 |
100,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michelle LaSpaluto
|
CHIEF FINANCIAL OFFICER |
Sale of securities on an exchange or to another person at price $ 1.04 per share. |
14 Feb 2024 |
1,940 |
110,999
(0%)
|
0%
|
1.0 |
2,023
|
Common Stock |
Andriole Michael T.
|
Director, PRESIDENT AND CEO |
Sale of securities on an exchange or to another person at price $ 1.04 per share. |
14 Feb 2024 |
1,744 |
447,021
(0%)
|
0%
|
1.0 |
1,809
|
Common Stock |
David Jakeman
|
VP OF FINANCE AND ACCOUNTING |
Sale of securities on an exchange or to another person at price $ 1.04 per share. |
14 Feb 2024 |
2,660 |
141,232
(0%)
|
0%
|
1.0 |
2,777
|
Common Stock |
T. Michael Andriole
|
Director, PRESIDENT AND CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Feb 2024 |
502,500 |
502,500
|
-
|
|
-
|
Stock Option (Right to Buy) |
Melemed S. Allen
|
CHIEF MEDICAL OFFICER |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Feb 2024 |
168,750 |
168,750
|
-
|
|
-
|
Stock Option (Right to Buy) |
Jakeman David
|
VP OF FINANCE AND ACCOUNTING |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Feb 2024 |
10,750 |
143,892
(0%)
|
0%
|
|
0
|
Common Stock |
Alrutz A. Michael
|
SVP AND GENERAL COUNSEL |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Feb 2024 |
131,250 |
131,250
|
-
|
|
-
|
Stock Option (Right to Buy) |
Andriole Michael T.
|
Director, PRESIDENT AND CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Feb 2024 |
83,750 |
448,765
(0%)
|
0%
|
|
0
|
Common Stock |
David Jakeman
|
VP OF FINANCE AND ACCOUNTING |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Feb 2024 |
64,500 |
64,500
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michelle LaSpaluto
|
CHIEF FINANCIAL OFFICER |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Feb 2024 |
25,000 |
112,939
(0%)
|
0%
|
|
0
|
Common Stock |
Allen Melemed S.
|
CHIEF MEDICAL OFFICER |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Feb 2024 |
28,125 |
86,430
(0%)
|
0%
|
|
0
|
Common Stock |
LaSpaluto Michelle
|
CHIEF FINANCIAL OFFICER |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Feb 2024 |
150,000 |
150,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michael Alrutz A.
|
SVP AND GENERAL COUNSEL |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Feb 2024 |
21,875 |
168,098
(0%)
|
0%
|
|
0
|
Common Stock |
T. Michael Andriole
|
Director, President and CEO |
Gift of securities by or to the insider at price $ 0.00 per share. |
29 Dec 2023 |
17,000 |
365,015
(0%)
|
0%
|
|
0
|
Common Stock |
Michelle LaSpaluto
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Dec 2023 |
17,000 |
17,000
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Michael T. Andriole
|
Director, President and CEO |
Grant, award, or other acquisition of securities at price $ 1.19 per share. |
01 Aug 2023 |
25,000 |
382,015
(0%)
|
0%
|
1.2 |
29,750
|
Common Stock |
Michael T. Andriole
|
Director, President and CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Aug 2023 |
150,000 |
150,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Patrick C. Machado
|
Director |
|
09 Jun 2023 |
60,000 |
60,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Martha J. Demski
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Jun 2023 |
60,000 |
60,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Fred A. Middleton
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Jun 2023 |
60,000 |
60,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Pratik S. Multani
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Jun 2023 |
60,000 |
60,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Catherine L. Gilliss
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Jun 2023 |
60,000 |
60,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Robert J. Meyer
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Jun 2023 |
60,000 |
60,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Victoria Vakiener
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Jun 2023 |
60,000 |
60,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michael T. Andriole
|
Chief Business Officer and CFO |
Purchase of securities on an exchange or from another person at price $ 1.14 per share. |
18 May 2023 |
51,700 |
357,015
(0%)
|
0%
|
1.1 |
59,150
|
Common Stock |
Michael Sherman
|
Director, Chief Executive Officer |
Purchase of securities on an exchange or from another person at price $ 1.12 per share. |
12 May 2023 |
75,015 |
87,000
(0%)
|
0%
|
1.1 |
84,122
|
Common Stock |
Michael Sherman
|
Director, Chief Executive Officer |
Purchase of securities on an exchange or from another person at price $ 1.13 per share. |
12 May 2023 |
11,985 |
11,985
(0%)
|
0%
|
1.1 |
13,530
|
Common Stock |
Martha J. Demski
|
Director |
Purchase of securities on an exchange or from another person at price $ 1.11 per share. |
10 May 2023 |
18,000 |
72,055
(0%)
|
0%
|
1.1 |
19,980
|
Common Stock |
Robert J. Meyer
|
Director |
Purchase of securities on an exchange or from another person at price $ 1.14 per share. |
08 May 2023 |
8,750 |
35,150
(0%)
|
0%
|
1.1 |
9,975
|
Common Stock |
Fred A. Middleton
|
Director |
Purchase of securities on an exchange or from another person at price $ 1.21 per share. |
28 Mar 2023 |
20,000 |
60,000
(0%)
|
0%
|
1.2 |
24,152
|
Common Stock |
David Jakeman
|
Principal Accounting Officer |
Sale of securities on an exchange or to another person at price $ 1.76 per share. |
26 Jan 2023 |
3,230 |
136,752
(0%)
|
0%
|
1.8 |
5,686
|
Common Stock |
Michael A. Alrutz
|
Principal Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 Jan 2023 |
21,450 |
142,015
(0%)
|
0%
|
|
0
|
Common Stock |
Michael A. Alrutz
|
Principal Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 Jan 2023 |
128,550 |
128,550
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michael Sherman
|
Director, Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 Jan 2023 |
557,050 |
557,050
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michael Sherman
|
Director, Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 Jan 2023 |
92,950 |
222,995
(0%)
|
0%
|
|
0
|
Common Stock |
Michael T. Andriole
|
Chief Business Officer and CFO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 Jan 2023 |
192,825 |
192,825
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michael T. Andriole
|
Chief Business Officer and CFO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 Jan 2023 |
32,175 |
294,899
(0%)
|
0%
|
|
0
|
Common Stock |
David Jakeman
|
Principal Accounting Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 Jan 2023 |
24,950 |
24,950
|
-
|
|
-
|
Stock Option (Right to Buy) |
David Jakeman
|
Principal Accounting Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 Jan 2023 |
12,450 |
139,982
(0%)
|
0%
|
|
0
|
Common Stock |
Allen S. Melemed
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 Jan 2023 |
154,260 |
154,260
|
-
|
|
-
|
Stock Option (Right to Buy) |
Allen S. Melemed
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 Jan 2023 |
25,740 |
47,887
(0%)
|
0%
|
|
0
|
Common Stock |
Fred A. Middleton
|
Director |
Purchase of securities on an exchange or from another person at price $ 1.86 per share. |
29 Sep 2022 |
20,000 |
40,000
(0%)
|
0%
|
1.9 |
37,176
|
Common Stock |
David Jakeman
|
Principal Accounting Officer |
Sale of securities on an exchange or to another person at price $ 1.86 per share. |
29 Sep 2022 |
4,400 |
127,532
(0%)
|
0%
|
1.9 |
8,185
|
Common Stock |
Michael T. Andriole
|
Chief Business Officer and CFO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
25 Aug 2022 |
50,000 |
450,000
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Michael T. Andriole
|
Chief Business Officer and CFO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.09 per share. |
25 Aug 2022 |
50,000 |
262,724
(0%)
|
0%
|
2.1 |
104,500
|
Common Stock |
Michael Sherman
|
Director, Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.09 per share. |
25 Jul 2022 |
100,000 |
125,364
(0%)
|
0%
|
2.1 |
209,000
|
Common Stock |
Michael Sherman
|
Director, Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
25 Jul 2022 |
100,000 |
1,150,000
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Patrick C. Machado
|
Director |
|
23 Jun 2022 |
50,000 |
50,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Martha J. Demski
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Jun 2022 |
50,000 |
50,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Fred A. Middleton
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Jun 2022 |
50,000 |
50,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Pratik S. Multani
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Jun 2022 |
50,000 |
50,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Catherine L. Gilliss
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Jun 2022 |
50,000 |
50,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Robert J. Meyer
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Jun 2022 |
50,000 |
50,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Victoria Vakiener
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Jun 2022 |
50,000 |
50,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Fred A. Middleton
|
Director |
Purchase of securities on an exchange or from another person at price $ 2.04 per share. |
19 May 2022 |
20,000 |
20,000
(0%)
|
0%
|
2.0 |
40,738
|
Common Stock |
Robert J. Meyer
|
Director |
Purchase of securities on an exchange or from another person at price $ 2.05 per share. |
19 May 2022 |
1,419 |
26,400
(0%)
|
0%
|
2.1 |
2,909
|
Common Stock |
Robert J. Meyer
|
Director |
Purchase of securities on an exchange or from another person at price $ 2.06 per share. |
19 May 2022 |
9,981 |
24,981
(0%)
|
0%
|
2.1 |
20,561
|
Common Stock |
Martha J. Demski
|
Director |
Purchase of securities on an exchange or from another person at price $ 1.61 per share. |
17 May 2022 |
10,000 |
54,055
(0%)
|
0%
|
1.6 |
16,100
|
Common Stock |
Michael T. Andriole
|
Chief Business Officer and CFO |
Purchase of securities on an exchange or from another person at price $ 1.71 per share. |
17 May 2022 |
15,000 |
212,724
(0%)
|
0%
|
1.7 |
25,635
|
Common Stock |
David Jakeman
|
Principal Accounting Officer |
Sale of securities on an exchange or to another person at price $ 5.56 per share. |
04 Feb 2022 |
3,300 |
117,666
(0%)
|
0%
|
5.6 |
18,355
|
Common Stock |
Michael Sherman
|
Director, Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jan 2022 |
875,000 |
875,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michael T. Andriole
|
Chief Business Officer and CFO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jan 2022 |
300,000 |
300,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
David Jakeman
|
Principal Accounting Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jan 2022 |
29,900 |
29,900
|
-
|
|
-
|
Stock Option (Right to Buy) |
David Jakeman
|
Principal Accounting Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jan 2022 |
14,900 |
120,966
(0%)
|
0%
|
|
0
|
Common Stock |
Allen S. Melemed
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Jan 2022 |
240,000 |
240,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
David Jakeman
|
Principal Accounting Officer |
Sale of securities on an exchange or to another person at price $ 6.19 per share. |
30 Sep 2021 |
4,590 |
106,066
(0%)
|
0%
|
6.2 |
28,412
|
Common Stock |
Fred A. Middleton
|
Director |
Purchase of securities on an exchange or from another person at price $ 7.78 per share. |
25 Jun 2021 |
3,050 |
200,573
(0%)
|
0%
|
7.8 |
23,729
|
Common Stock |
Fred A. Middleton
|
Director |
Purchase of securities on an exchange or from another person at price $ 7.83 per share. |
25 Jun 2021 |
6,950 |
207,523
(0%)
|
0%
|
7.8 |
54,419
|
Common Stock |
Patrick C. Machado
|
Director |
|
23 Jun 2021 |
35,000 |
35,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Martha J. Demski
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Jun 2021 |
35,000 |
35,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Fred A. Middleton
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Jun 2021 |
35,000 |
35,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Pratik S. Multani
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Jun 2021 |
35,000 |
35,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Catherine L. Gilliss
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Jun 2021 |
35,000 |
35,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Robert J. Meyer
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Jun 2021 |
35,000 |
35,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Victoria Vakiener
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Jun 2021 |
35,000 |
35,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Victoria Vakiener
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
22 Apr 2021 |
60,000 |
60,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
David Jakeman
|
Principal Accounting Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.35 per share. |
05 Apr 2021 |
5,250 |
103,989
(0%)
|
0%
|
2.4 |
12,338
|
Common Stock |
David Jakeman
|
Principal Accounting Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
05 Apr 2021 |
5,250 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
David Jakeman
|
Principal Accounting Officer |
Sale of securities on an exchange or to another person at price $ 9.68 per share. |
05 Apr 2021 |
1,284 |
102,705
(0%)
|
0%
|
9.7 |
12,427
|
Common Stock |
Robert J. Meyer
|
Director |
Purchase of securities on an exchange or from another person at price $ 9.80 per share. |
01 Mar 2021 |
1,500 |
15,000
(0%)
|
0%
|
9.8 |
14,700
|
Common Stock |
David Jakeman
|
Principal Accounting Officer |
Sale of securities on an exchange or to another person at price $ 8.61 per share. |
28 Jan 2021 |
3,211 |
96,906
(0%)
|
0%
|
8.6 |
27,650
|
Common Stock |
Michael Sherman
|
Director, Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
22 Jan 2021 |
700,000 |
700,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michael T. Andriole
|
Chief Business Officer and CFO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
22 Jan 2021 |
250,000 |
250,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
David Jakeman
|
Principal Accounting Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
22 Jan 2021 |
15,000 |
100,117
(0%)
|
0%
|
|
0
|
Common Stock |
David Jakeman
|
Principal Accounting Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
22 Jan 2021 |
30,000 |
30,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Allen S. Melemed
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
22 Jan 2021 |
190,000 |
190,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
David Jakeman
|
Principal Accounting Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
21 Dec 2020 |
1,500 |
1,500
|
-
|
|
-
|
Stock Option (Right to Buy) |
Martha J. Demski
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
17 Nov 2020 |
7,042 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
Martha J. Demski
|
Director |
Gift of securities by or to the insider at price $ 0.00 per share. |
17 Nov 2020 |
7,042 |
44,055
(0%)
|
0%
|
|
0
|
Common Stock |
Martha J. Demski
|
Director |
Gift of securities by or to the insider at price $ 0.00 per share. |
17 Nov 2020 |
7,042 |
0
(0%)
|
0%
|
|
0
|
Common Stock |
Martha J. Demski
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.35 per share. |
17 Nov 2020 |
7,042 |
7,042
(0%)
|
0%
|
2.4 |
16,549
|
Common Stock |
David Jakeman
|
Principal Accounting Officer |
Sale of securities on an exchange or to another person at price $ 2.48 per share. |
02 Oct 2020 |
4,270 |
85,117
(0%)
|
0%
|
2.5 |
10,590
|
Common Stock |
Robert J. Meyer
|
Director |
Purchase of securities on an exchange or from another person at price $ 2.92 per share. |
19 Aug 2020 |
3,500 |
13,500
(0%)
|
0%
|
2.9 |
10,220
|
Common Stock |
Martha J. Demski
|
Director |
Sale of securities on an exchange or to another person at price $ 3.25 per share. |
10 Aug 2020 |
1,584 |
0
(0%)
|
0%
|
3.3 |
5,148
|
Common Stock |
Martha J. Demski
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Aug 2020 |
1,584 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
Martha J. Demski
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.16 per share. |
10 Aug 2020 |
1,584 |
1,584
(0%)
|
0%
|
3.2 |
5,005
|
Common Stock |
Martha J. Demski
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
06 Aug 2020 |
2,500 |
1,584
|
-
|
|
-
|
Stock Option (Right to Buy) |
Martha J. Demski
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
06 Aug 2020 |
2,500 |
4,084
|
-
|
|
-
|
Stock Option (Right to Buy) |
Martha J. Demski
|
Director |
Sale of securities on an exchange or to another person at price $ 3.25 per share. |
06 Aug 2020 |
2,500 |
0
(0%)
|
0%
|
3.3 |
8,125
|
Common Stock |
Martha J. Demski
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.16 per share. |
06 Aug 2020 |
2,500 |
2,500
(0%)
|
0%
|
3.2 |
7,900
|
Common Stock |
Martha J. Demski
|
Director |
Sale of securities on an exchange or to another person at price $ 3.29 per share. |
06 Aug 2020 |
2,500 |
0
(0%)
|
0%
|
3.3 |
8,224
|
Common Stock |
Martha J. Demski
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.16 per share. |
06 Aug 2020 |
2,500 |
2,500
(0%)
|
0%
|
3.2 |
7,900
|
Common Stock |
Martha J. Demski
|
Director |
Sale of securities on an exchange or to another person at price $ 3.25 per share. |
04 Aug 2020 |
5,000 |
0
(0%)
|
0%
|
3.3 |
16,250
|
Common Stock |
Martha J. Demski
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.16 per share. |
04 Aug 2020 |
5,000 |
5,000
(0%)
|
0%
|
3.2 |
15,800
|
Common Stock |
Martha J. Demski
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Aug 2020 |
2,500 |
6,584
|
-
|
|
-
|
Stock Option (Right to Buy) |
Martha J. Demski
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Aug 2020 |
5,000 |
9,084
|
-
|
|
-
|
Stock Option (Right to Buy) |
Martha J. Demski
|
Director |
Sale of securities on an exchange or to another person at price $ 3.27 per share. |
04 Aug 2020 |
2,500 |
0
(0%)
|
0%
|
3.3 |
8,187
|
Common Stock |
Martha J. Demski
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.16 per share. |
04 Aug 2020 |
2,500 |
2,500
(0%)
|
0%
|
3.2 |
7,900
|
Common Stock |
Allen S. Melemed
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
19 Jun 2020 |
400,000 |
400,000
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Patrick C. Machado
|
Director |
|
11 Jun 2020 |
35,000 |
35,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Martha J. Demski
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jun 2020 |
35,000 |
35,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Fred A. Middleton
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jun 2020 |
35,000 |
35,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Pratik S. Multani
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jun 2020 |
35,000 |
35,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Catherine L. Gilliss
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jun 2020 |
35,000 |
35,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Robert J. Meyer
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jun 2020 |
35,000 |
35,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Edward F. Greissing
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jun 2020 |
35,000 |
35,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michael T. Andriole
|
Chief Business Officer |
Purchase of securities on an exchange or from another person at price $ 1.43 per share. |
16 Mar 2020 |
33,300 |
149,729
(0%)
|
0%
|
1.4 |
47,522
|
Common Stock |
Fred A. Middleton
|
Director |
Purchase of securities on an exchange or from another person at price $ 1.40 per share. |
12 Mar 2020 |
50,000 |
197,523
(0%)
|
0%
|
1.4 |
69,900
|
Common Stock |
Michael Sherman
|
Director, Chief Executive Officer |
Purchase of securities on an exchange or from another person at price $ 1.45 per share. |
12 Mar 2020 |
72,995 |
102,995
(0%)
|
0%
|
1.4 |
105,653
|
Common Stock |
Pratik S. Multani
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
21 Feb 2020 |
60,000 |
60,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
William Garrett Nichols
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 1.68 per share. |
07 Feb 2020 |
8,805 |
260,066
(0%)
|
0%
|
1.7 |
14,830
|
Common Stock |
William Garrett Nichols
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 1.70 per share. |
07 Feb 2020 |
2,550 |
268,871
(0%)
|
0%
|
1.7 |
4,335
|
Common Stock |
David Jakeman
|
Principal Accounting Officer |
Sale of securities on an exchange or to another person at price $ 1.70 per share. |
07 Feb 2020 |
2,290 |
87,876
(0%)
|
0%
|
1.7 |
3,893
|
Common Stock |
Michael Sherman
|
Director, Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
21 Jan 2020 |
632,500 |
632,500
|
-
|
|
-
|
Stock Option (Right to Buy) |
William Garrett Nichols
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
21 Jan 2020 |
192,500 |
192,500
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michael T. Andriole
|
Chief Business Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
21 Jan 2020 |
192,500 |
192,500
|
-
|
|
-
|
Stock Option (Right to Buy) |
David Jakeman
|
Principal Accounting Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
21 Jan 2020 |
14,160 |
90,166
(0%)
|
0%
|
|
0
|
Common Stock |
David Jakeman
|
Principal Accounting Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
21 Jan 2020 |
28,320 |
28,320
|
-
|
|
-
|
Stock Option (Right to Buy) |
William Garrett Nichols
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 2.15 per share. |
07 Jan 2020 |
30,680 |
271,421
(0%)
|
0%
|
2.2 |
66,045
|
Common Stock |
Fred A. Middleton
|
None |
Purchase of securities on an exchange or from another person at price $ 1.82 per share. |
11 Nov 2019 |
30,000 |
147,523
(0%)
|
0%
|
1.8 |
54,567
|
Common Stock |
Fred A. Middleton
|
None |
Purchase of securities on an exchange or from another person at price $ 1.66 per share. |
11 Nov 2019 |
20,000 |
117,523
(0%)
|
0%
|
1.7 |
33,190
|
Common Stock |
Robert J. Meyer
|
None |
Purchase of securities on an exchange or from another person at price $ 1.58 per share. |
06 Nov 2019 |
10,000 |
10,000
(0%)
|
0%
|
1.6 |
15,797
|
Common Stock |
Michael T. Andriole
|
Chief Business Officer |
Purchase of securities on an exchange or from another person at price $ 1.56 per share. |
06 Nov 2019 |
100,000 |
100,000
(0%)
|
0%
|
1.6 |
156,000
|
Common Stock |
David Jakeman
|
Principal Accounting Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Sep 2019 |
56,000 |
76,006
(0%)
|
0%
|
|
0
|
Common Stock |
William Garrett Nichols
|
Chief Medical Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.49 per share. |
25 Jul 2019 |
7,625 |
300,056
(0%)
|
0%
|
3.5 |
26,634
|
Common Stock |
Patrick C. Machado
|
None |
|
20 Jun 2019 |
21,000 |
21,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Martha J. Demski
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2019 |
21,000 |
21,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Ronald C. Renaud
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2019 |
21,000 |
21,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Fred A. Middleton
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2019 |
21,000 |
21,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
James M. Daly
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2019 |
21,000 |
21,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Catherine L. Gilliss
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2019 |
21,000 |
21,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Robert J. Meyer
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2019 |
21,000 |
21,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Edward F. Greissing
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2019 |
21,000 |
21,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
David Jakeman
|
Principal Accounting Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2019 |
10,000 |
10,000
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Martha J. Demski
|
None |
Purchase of securities on an exchange or from another person at price $ 3.60 per share. |
28 May 2019 |
18,000 |
37,013
(0%)
|
0%
|
3.6 |
64,800
|
Common Stock |
Timothy W. Trost
|
SVP, CFO & Secretary |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.44 per share. |
22 May 2019 |
3,795 |
217,088
(0%)
|
0%
|
3.4 |
13,066
|
Common Stock |
William Garrett Nichols
|
Chief Medical Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.47 per share. |
21 May 2019 |
4,695 |
307,681
(0%)
|
0%
|
3.5 |
16,270
|
Common Stock |
Michael Sherman
|
Director, Chief Executive Officer |
Purchase of securities on an exchange or from another person at price $ 3.48 per share. |
20 May 2019 |
30,000 |
30,000
(0%)
|
0%
|
3.5 |
104,316
|
Common Stock |
Fred A. Middleton
|
None |
Purchase of securities on an exchange or from another person at price $ 2.92 per share. |
10 May 2019 |
30,000 |
97,523
(0%)
|
0%
|
2.9 |
87,678
|
Common Stock |
Michael Sherman
|
Director, Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Apr 2019 |
1,250,000 |
1,250,000
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Michael T. Andriole
|
Chief Business Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Apr 2019 |
500,000 |
500,000
|
-
|
|
-
|
Employee Stock Option (Right to Buy) |
Michael A. Alrutz
|
Principal Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
05 Feb 2019 |
100,000 |
156,645
(0%)
|
0%
|
|
0
|
Common Stock |
Timothy W. Trost
|
SVP, CFO & Secretary |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
05 Feb 2019 |
100,000 |
214,530
(0%)
|
0%
|
|
0
|
Common Stock |
William Garrett Nichols
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
05 Feb 2019 |
100,000 |
312,376
(0%)
|
0%
|
|
0
|
Common Stock |
Timothy W. Trost
|
SVP, CFO & Secretary |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.20 per share. |
29 Jan 2019 |
2,588 |
114,530
(0%)
|
0%
|
2.2 |
5,694
|
Common Stock |
William Garrett Nichols
|
Chief Medical Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.20 per share. |
29 Jan 2019 |
3,095 |
212,376
(0%)
|
0%
|
2.2 |
6,821
|
Common Stock |
M. Michelle Berrey
|
Director, President and CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Jan 2019 |
400,000 |
400,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Timothy W. Trost
|
SVP, CFO & Secretary |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Jan 2019 |
176,000 |
176,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
William Garrett Nichols
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Jan 2019 |
200,000 |
200,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
William Garrett Nichols
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
23 Jan 2019 |
125,000 |
215,471
(0%)
|
0%
|
|
0
|
Common Stock |
Patrick C. Machado
|
None |
|
20 Jun 2018 |
21,000 |
21,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Martha J. Demski
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2018 |
21,000 |
21,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Ronald C. Renaud
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2018 |
21,000 |
21,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Fred A. Middleton
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2018 |
21,000 |
21,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
James M. Daly
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2018 |
21,000 |
21,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Catherine L. Gilliss
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2018 |
21,000 |
21,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Robert J. Meyer
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2018 |
21,000 |
21,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Edward F. Greissing
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
20 Jun 2018 |
21,000 |
21,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
M. Michelle Berrey
|
Director, President and CEO |
Purchase of securities on an exchange or from another person at price $ 4.50 per share. |
12 Jun 2018 |
10,000 |
99,685
(0%)
|
0%
|
4.5 |
45,015
|
Common Stock |
Ernest Mario
|
None |
Sale of securities on an exchange or to another person at price $ 4.80 per share. |
17 May 2018 |
30,000 |
123,167
(0%)
|
0%
|
4.8 |
143,931
|
Common Stock |
Ernest Mario
|
None |
Sale of securities on an exchange or to another person at price $ 4.81 per share. |
17 May 2018 |
15,000 |
108,167
(0%)
|
0%
|
4.8 |
72,143
|
Common Stock |
Ernest Mario
|
None |
Sale of securities on an exchange or to another person at price $ 4.79 per share. |
16 May 2018 |
30,000 |
153,167
(0%)
|
0%
|
4.8 |
143,808
|
Common Stock |
Ernest Mario
|
None |
Sale of securities on an exchange or to another person at price $ 4.69 per share. |
15 May 2018 |
30,000 |
183,167
(0%)
|
0%
|
4.7 |
140,808
|
Common Stock |
Linda M. Richardson
|
Chief Commercial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.66 per share. |
14 May 2018 |
4,545 |
54,161
(0%)
|
0%
|
4.7 |
21,199
|
Common Stock |
William Garrett Nichols
|
Chief Medical Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.66 per share. |
14 May 2018 |
5,680 |
90,471
(0%)
|
0%
|
4.7 |
26,490
|
Common Stock |
Ernest Mario
|
None |
Sale of securities on an exchange or to another person at price $ 4.57 per share. |
11 May 2018 |
7,143 |
258,577
(0%)
|
0%
|
4.6 |
32,614
|
Common Stock |
Ernest Mario
|
None |
Sale of securities on an exchange or to another person at price $ 4.63 per share. |
11 May 2018 |
22,857 |
235,720
(0%)
|
0%
|
4.6 |
105,766
|
Common Stock |
Ernest Mario
|
None |
Sale of securities on an exchange or to another person at price $ 4.67 per share. |
11 May 2018 |
22,553 |
213,167
(0%)
|
0%
|
4.7 |
105,232
|
Common Stock |
Ernest Mario
|
None |
Sale of securities on an exchange or to another person at price $ 4.60 per share. |
10 May 2018 |
2,815 |
265,720
(0%)
|
0%
|
4.6 |
12,949
|
Common Stock |
Martha J. Demski
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 May 2018 |
4,225 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
Martha J. Demski
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.57 per share. |
09 May 2018 |
4,225 |
19,013
(0%)
|
0%
|
1.6 |
6,633
|
Common Stock |
M. Michelle Berrey
|
Director, President and CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.26 per share. |
08 May 2018 |
11,250 |
325,256
(0%)
|
0%
|
4.3 |
47,925
|
Common Stock |
M. Michelle Berrey
|
Director, President and CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
08 May 2018 |
11,250 |
15,161
|
-
|
|
-
|
Stock Option (Right to Buy) |
Fred A. Middleton
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 Mar 2018 |
42,000 |
42,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Robert J. Meyer
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 Mar 2018 |
42,000 |
42,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Edward F. Greissing
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 Mar 2018 |
42,000 |
42,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
M. Michelle Berrey
|
Director, President and CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.26 per share. |
06 Mar 2018 |
10,071 |
311,336
(0%)
|
0%
|
4.3 |
42,902
|
Common Stock |
M. Michelle Berrey
|
Director, President and CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
06 Mar 2018 |
10,071 |
26,411
|
-
|
|
-
|
Stock Option (Right to Buy) |
Linda M. Richardson
|
Chief Commercial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.67 per share. |
02 Feb 2018 |
2,290 |
58,706
(0%)
|
0%
|
4.7 |
10,691
|
Common Stock |
William Garrett Nichols
|
Chief Medical Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.67 per share. |
02 Feb 2018 |
2,330 |
96,151
(0%)
|
0%
|
4.7 |
10,872
|
Common Stock |
M. Michelle Berrey
|
Director, President and CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 Jan 2018 |
400,000 |
400,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Timothy W. Trost
|
SVP, CFO & Secretary |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 Jan 2018 |
141,750 |
141,750
|
-
|
|
-
|
Stock Option (Right to Buy) |
Linda M. Richardson
|
Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 Jan 2018 |
135,000 |
135,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
William Garrett Nichols
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 Jan 2018 |
148,500 |
148,500
|
-
|
|
-
|
Stock Option (Right to Buy) |
Linda M. Richardson
|
Chief Commercial Officer |
Sale of securities on an exchange or to another person at price $ 4.47 per share. |
01 Dec 2017 |
19,833 |
60,996
(0%)
|
0%
|
4.5 |
88,673
|
Common Stock |
Patrick C. Machado
|
None |
|
28 Jun 2017 |
21,000 |
21,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Martha J. Demski
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 Jun 2017 |
21,000 |
21,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Ronald C. Renaud
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 Jun 2017 |
21,000 |
21,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Ernest Mario
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 Jun 2017 |
21,000 |
21,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Ernest Mario
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 Jun 2017 |
6,341 |
6,341
|
-
|
|
-
|
Stock Option (Right to Buy) |
John M. Leonard
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 Jun 2017 |
21,000 |
21,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
James M. Daly
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 Jun 2017 |
21,000 |
21,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
James Niedel
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 Jun 2017 |
21,000 |
21,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Catherine L. Gilliss
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 Jun 2017 |
21,000 |
21,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
M. Michelle Berrey
|
Director, President and CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.26 per share. |
21 Jun 2017 |
23,474 |
323,947
(0%)
|
0%
|
4.3 |
99,999
|
Common Stock |
M. Michelle Berrey
|
Director, President and CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
21 Jun 2017 |
23,474 |
36,482
|
-
|
|
-
|
Stock Option (Right to Buy) |
Linda M. Richardson
|
Chief Commercial Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.68 per share. |
12 May 2017 |
10,167 |
80,829
(0%)
|
0%
|
4.7 |
47,577
|
Common Stock |
William Garrett Nichols
|
Chief Medical Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.68 per share. |
12 May 2017 |
12,712 |
98,481
(0%)
|
0%
|
4.7 |
59,464
|
Common Stock |
M. Michelle Berrey
|
Director, President and CEO |
Grant, award, or other acquisition of securities at price $ 4.10 per share. |
10 Mar 2017 |
4,523 |
366,684
(0%)
|
0%
|
4.1 |
18,531
|
Common Stock |
Timothy W. Trost
|
SVP, CFO & Secretary |
Grant, award, or other acquisition of securities at price $ 4.10 per share. |
10 Mar 2017 |
5,186 |
111,931
(0%)
|
0%
|
4.1 |
21,247
|
Common Stock |
William Garrett Nichols
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 4.10 per share. |
10 Mar 2017 |
587 |
111,193
(0%)
|
0%
|
4.1 |
2,405
|
Common Stock |
M. Michelle Berrey
|
Director, President and CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 Jan 2017 |
148,000 |
148,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
M. Michelle Berrey
|
Director, President and CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 Jan 2017 |
74,000 |
362,161
(0%)
|
0%
|
|
0
|
Common Stock |
Timothy W. Trost
|
SVP, CFO & Secretary |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 Jan 2017 |
25,375 |
106,745
(0%)
|
0%
|
|
0
|
Common Stock |
Timothy W. Trost
|
SVP, CFO & Secretary |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 Jan 2017 |
50,750 |
50,750
|
-
|
|
-
|
Stock Option (Right to Buy) |
Linda M. Richardson
|
Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 Jan 2017 |
30,375 |
90,996
(0%)
|
0%
|
|
0
|
Common Stock |
Linda M. Richardson
|
Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 Jan 2017 |
60,750 |
60,750
|
-
|
|
-
|
Stock Option (Right to Buy) |
William Garrett Nichols
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 Jan 2017 |
30,375 |
110,606
(0%)
|
0%
|
|
0
|
Common Stock |
William Garrett Nichols
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 Jan 2017 |
60,750 |
60,750
|
-
|
|
-
|
Stock Option (Right to Buy) |
Ernest Mario
|
None |
Sale of securities on an exchange or to another person at price $ 0.00 per share. |
27 Dec 2016 |
72,073 |
296,462
|
-
|
|
-
|
Common Stock |
Ernest Mario
|
None |
Sale of securities on an exchange or to another person at price $ 0.00 per share. |
27 Dec 2016 |
3,636 |
292,826
|
-
|
|
-
|
Common Stock |
Ernest Mario
|
None |
Sale of securities on an exchange or to another person at price $ 0.00 per share. |
27 Dec 2016 |
4,000 |
288,826
|
-
|
|
-
|
Common Stock |
Ernest Mario
|
None |
Sale of securities on an exchange or to another person at price $ 0.00 per share. |
27 Dec 2016 |
20,291 |
268,535
|
-
|
|
-
|
Common Stock |
M. Michelle Berrey
|
Director, President and CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
29 Nov 2016 |
2,400 |
59,956
|
-
|
|
-
|
Stock Option (Right to Buy) |
M. Michelle Berrey
|
Director, President and CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
29 Nov 2016 |
2,400 |
288,161
|
-
|
|
-
|
Common Stock |
John M. Leonard
|
None |
Sale of securities on an exchange or to another person at price $ 0.00 per share. |
15 Sep 2016 |
5,000 |
0
|
-
|
|
-
|
Common Stock |
M. Michelle Berrey
|
Director, President and CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Sep 2016 |
4,523 |
285,761
|
-
|
|
-
|
Common Stock |
Timothy W. Trost
|
SVP, CFO & Secretary |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Sep 2016 |
4,638 |
81,370
|
-
|
|
-
|
Common Stock |
William Garrett Nichols
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Sep 2016 |
3,566 |
80,231
|
-
|
|
-
|
Common Stock |
M. Michelle Berrey
|
Director, President and CEO |
Purchase of securities on an exchange or from another person at price $ 0.00 per share. |
29 Aug 2016 |
22,417 |
281,238
|
-
|
|
-
|
Common Stock |
Ernest Mario
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 Jun 2016 |
9,000 |
9,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Ernest Mario
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 Jun 2016 |
9,634 |
9,634
|
-
|
|
-
|
Stock Option (Right to Buy) |
Ernest Mario
|
None |
Purchase of securities on an exchange or from another person at price $ 0.00 per share. |
24 Jun 2016 |
50,000 |
381,440
|
-
|
|
-
|
Common Stock |
Martha J. Demski
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 Jun 2016 |
9,000 |
9,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
C. Patrick Machado
|
None |
|
24 Jun 2016 |
9,000 |
9,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Ronald C. Renaud
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 Jun 2016 |
9,000 |
9,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
John M. Leonard
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 Jun 2016 |
9,000 |
9,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
M. Michelle Berrey
|
Director, President and CEO |
Purchase of securities on an exchange or from another person at price $ 0.00 per share. |
24 Jun 2016 |
13,188 |
258,821
|
-
|
|
-
|
Common Stock |
Lisa Ricciardi
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 Jun 2016 |
9,000 |
9,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
James M. Daly
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 Jun 2016 |
9,000 |
9,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
James Niedel
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 Jun 2016 |
9,000 |
9,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Catherine L. Gilliss
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
24 Jun 2016 |
9,000 |
9,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Ernest Mario
|
None |
Purchase of securities on an exchange or from another person at price $ 0.00 per share. |
13 May 2016 |
10,000 |
331,440
|
-
|
|
-
|
Common Stock |
Ernest Mario
|
None |
Purchase of securities on an exchange or from another person at price $ 0.00 per share. |
10 May 2016 |
800 |
297,240
|
-
|
|
-
|
Common Stock |
Ernest Mario
|
None |
Purchase of securities on an exchange or from another person at price $ 0.00 per share. |
10 May 2016 |
24,200 |
321,440
|
-
|
|
-
|
Common Stock |
M. Michelle Berrey
|
Director, President and CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 May 2016 |
100,000 |
245,633
|
-
|
|
-
|
Common Stock |
Timothy W. Trost
|
SVP, CFO & Secretary |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 May 2016 |
60,000 |
76,732
|
-
|
|
-
|
Common Stock |
Linda M. Richardson
|
Chief Commerical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 May 2016 |
60,000 |
60,621
|
-
|
|
-
|
Common Stock |
William Garrett Nichols
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 May 2016 |
75,000 |
76,665
|
-
|
|
-
|
Common Stock |
Ernest Mario
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 May 2016 |
1,761 |
15,845
|
-
|
|
-
|
Stock Option (Right to Buy) |
Ernest Mario
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 May 2016 |
1,761 |
296,440
|
-
|
|
-
|
Common Stock |
Ernest Mario
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Apr 2016 |
1,760 |
17,606
|
-
|
|
-
|
Stock Option (Right to Buy) |
Ernest Mario
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Apr 2016 |
1,760 |
294,679
|
-
|
|
-
|
Common Stock |
Ernest Mario
|
None |
Purchase of securities on an exchange or from another person at price $ 0.00 per share. |
15 Mar 2016 |
20,000 |
287,919
|
-
|
|
-
|
Common Stock |
Ernest Mario
|
None |
Purchase of securities on an exchange or from another person at price $ 0.00 per share. |
15 Mar 2016 |
5,000 |
292,919
|
-
|
|
-
|
Common Stock |
Ernest Mario
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
07 Mar 2016 |
1,761 |
19,366
|
-
|
|
-
|
Stock Option (Right to Buy) |
Ernest Mario
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
07 Mar 2016 |
1,761 |
267,919
|
-
|
|
-
|
Common Stock |
M. Michelle Berrey
|
Director, President and CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Mar 2016 |
11,001 |
62,356
|
-
|
|
-
|
Stock Option (Right to Buy) |
M. Michelle Berrey
|
Director, President and CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Mar 2016 |
11,001 |
145,633
|
-
|
|
-
|
Common Stock |
Ernest Mario
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
08 Feb 2016 |
1,760 |
21,127
|
-
|
|
-
|
Stock Option (Right to Buy) |
Ernest Mario
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
08 Feb 2016 |
1,760 |
266,158
|
-
|
|
-
|
Common Stock |
Ernest Mario
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2016 |
1,761 |
22,887
|
-
|
|
-
|
Stock Option (Right to Buy) |
Ernest Mario
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
13 Jan 2016 |
1,761 |
264,398
|
-
|
|
-
|
Common Stock |
M. Michelle Berrey
|
Director, President and CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Jan 2016 |
483,600 |
483,600
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michael D. Rogers
|
Chief Development Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Jan 2016 |
178,000 |
178,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Timothy W. Trost
|
SVP, CFO & Secretary |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Jan 2016 |
178,000 |
178,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Linda M. Richardson
|
Chief Commerical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Jan 2016 |
178,000 |
178,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
William Garrett Nichols
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Jan 2016 |
178,000 |
178,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Ernest Mario
|
None |
Purchase of securities on an exchange or from another person at price $ 0.00 per share. |
29 Dec 2015 |
125,000 |
262,637
|
-
|
|
-
|
Common Stock |
C. Patrick Machado
|
None |
|
29 Dec 2015 |
10,000 |
10,000
|
-
|
|
-
|
Common Stock |
Ernest Mario
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 Dec 2015 |
1,760 |
24,648
|
-
|
|
-
|
Stock Option (Right to Buy) |
Ernest Mario
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 Dec 2015 |
1,760 |
137,637
|
-
|
|
-
|
Common Stock |
Ernest Mario
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
06 Nov 2015 |
1,761 |
26,408
|
-
|
|
-
|
Stock Option (Right to Buy) |
Ernest Mario
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
06 Nov 2015 |
1,761 |
135,877
|
-
|
|
-
|
Common Stock |
Martha J. Demski
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
02 Nov 2015 |
1,126 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
Martha J. Demski
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
02 Nov 2015 |
1,126 |
1,126
|
-
|
|
-
|
Common Stock |
Martha J. Demski
|
None |
Sale of securities on an exchange or to another person at price $ 0.00 per share. |
02 Nov 2015 |
100 |
1,026
|
-
|
|
-
|
Common Stock |
Martha J. Demski
|
None |
Sale of securities on an exchange or to another person at price $ 0.00 per share. |
02 Nov 2015 |
100 |
926
|
-
|
|
-
|
Common Stock |
Martha J. Demski
|
None |
Sale of securities on an exchange or to another person at price $ 0.00 per share. |
02 Nov 2015 |
926 |
0
|
-
|
|
-
|
Common Stock |
Ernest Mario
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
06 Oct 2015 |
1,761 |
28,169
|
-
|
|
-
|
Stock Option (Right to Buy) |
Ernest Mario
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
06 Oct 2015 |
1,761 |
134,116
|
-
|
|
-
|
Common Stock |
Martha J. Demski
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Oct 2015 |
2,000 |
1,126
|
-
|
|
-
|
Stock Option (Right to Buy) |
Martha J. Demski
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Oct 2015 |
2,000 |
2,000
|
-
|
|
-
|
Common Stock |
Martha J. Demski
|
None |
Sale of securities on an exchange or to another person at price $ 0.00 per share. |
01 Oct 2015 |
1,800 |
200
|
-
|
|
-
|
Common Stock |
Martha J. Demski
|
None |
Sale of securities on an exchange or to another person at price $ 0.00 per share. |
01 Oct 2015 |
200 |
0
|
-
|
|
-
|
Common Stock |
Ernest Mario
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Sep 2015 |
1,760 |
29,930
|
-
|
|
-
|
Stock Option (Right to Buy) |
Ernest Mario
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Sep 2015 |
832 |
8,319
|
-
|
|
-
|
Stock Option (Right to Buy) |
Ernest Mario
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Sep 2015 |
1,760 |
131,523
|
-
|
|
-
|
Common Stock |
Ernest Mario
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Sep 2015 |
832 |
132,355
|
-
|
|
-
|
Common Stock |
Martha J. Demski
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Sep 2015 |
2,000 |
3,126
|
-
|
|
-
|
Stock Option (Right to Buy) |
Martha J. Demski
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Sep 2015 |
2,000 |
2,000
|
-
|
|
-
|
Common Stock |
Martha J. Demski
|
None |
Sale of securities on an exchange or to another person at price $ 0.00 per share. |
01 Sep 2015 |
1,562 |
438
|
-
|
|
-
|
Common Stock |
Martha J. Demski
|
None |
Sale of securities on an exchange or to another person at price $ 0.00 per share. |
01 Sep 2015 |
438 |
0
|
-
|
|
-
|
Common Stock |
M. Michelle Berrey
|
Director, President and CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
26 Aug 2015 |
2,796 |
58,713
|
-
|
|
-
|
Stock Option (Right to Buy) |
M. Michelle Berrey
|
Director, President and CEO |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
26 Aug 2015 |
2,796 |
133,434
|
-
|
|
-
|
Common Stock |
John M. Leonard
|
None |
Purchase of securities on an exchange or from another person at price $ 0.00 per share. |
21 Aug 2015 |
1,000 |
1,000
|
-
|
|
-
|
Common Stock |
Timothy W. Trost
|
SVP, CFO & Secretary |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
12 Aug 2015 |
5,333 |
44,734
|
-
|
|
-
|
Stock Option (Right to Buy) |
Timothy W. Trost
|
SVP, CFO & Secretary |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
12 Aug 2015 |
5,333 |
15,183
|
-
|
|
-
|
Common Stock |
Ernest Mario
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
06 Aug 2015 |
3,521 |
31,690
|
-
|
|
-
|
Stock Option (Right to Buy) |
Ernest Mario
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
06 Aug 2015 |
750 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
Ernest Mario
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
06 Aug 2015 |
129 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
Ernest Mario
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
06 Aug 2015 |
832 |
9,151
|
-
|
|
-
|
Stock Option (Right to Buy) |
Ernest Mario
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
06 Aug 2015 |
3,521 |
128,052
|
-
|
|
-
|
Common Stock |
Ernest Mario
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
06 Aug 2015 |
750 |
128,802
|
-
|
|
-
|
Common Stock |
Ernest Mario
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
06 Aug 2015 |
129 |
128,931
|
-
|
|
-
|
Common Stock |
Ernest Mario
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
06 Aug 2015 |
832 |
129,763
|
-
|
|
-
|
Common Stock |
Martha J. Demski
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
03 Aug 2015 |
2,000 |
5,126
|
-
|
|
-
|
Stock Option (Right to Buy) |
Martha J. Demski
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
03 Aug 2015 |
2,000 |
2,000
|
-
|
|
-
|
Common Stock |
Martha J. Demski
|
None |
Sale of securities on an exchange or to another person at price $ 0.00 per share. |
03 Aug 2015 |
2,000 |
0
|
-
|
|
-
|
Common Stock |
Timothy W. Trost
|
SVP, CFO & Secretary |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
17 Jul 2015 |
28,000 |
78,461
|
-
|
|
-
|
Stock Option (Right to Buy) |
Timothy W. Trost
|
SVP, CFO & Secretary |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
17 Jul 2015 |
28,000 |
37,850
|
-
|
|
-
|
Common Stock |
Timothy W. Trost
|
SVP, CFO & Secretary |
Sale of securities on an exchange or to another person at price $ 0.00 per share. |
17 Jul 2015 |
28,000 |
9,850
|
-
|
|
-
|
Common Stock |
Martha J. Demski
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Jul 2015 |
2,000 |
7,126
|
-
|
|
-
|
Stock Option (Right to Buy) |
Martha J. Demski
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Jul 2015 |
2,000 |
2,000
|
-
|
|
-
|
Common Stock |
Martha J. Demski
|
None |
Sale of securities on an exchange or to another person at price $ 0.00 per share. |
01 Jul 2015 |
1,300 |
700
|
-
|
|
-
|
Common Stock |
Martha J. Demski
|
None |
Sale of securities on an exchange or to another person at price $ 0.00 per share. |
01 Jul 2015 |
700 |
0
|
-
|
|
-
|
Common Stock |
Ernest Mario
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
22 Jun 2015 |
9,983 |
9,983
|
-
|
|
-
|
Stock Option (Right to Buy) |
Martha J. Demski
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
22 Jun 2015 |
9,000 |
9,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
C. Patrick Machado
|
None |
|
22 Jun 2015 |
9,000 |
9,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Ronald C. Renaud
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
22 Jun 2015 |
9,000 |
9,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
John M. Leonard
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
22 Jun 2015 |
9,000 |
9,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Lisa Ricciardi
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
22 Jun 2015 |
9,000 |
9,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
James M. Daly
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
22 Jun 2015 |
9,000 |
9,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Timothy W. Trost
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
22 Jun 2015 |
9,000 |
9,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
James Niedel
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
22 Jun 2015 |
9,000 |
9,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Catherine L. Gilliss
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
22 Jun 2015 |
9,000 |
9,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Ernest Mario
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2015 |
3,521 |
35,211
|
-
|
|
-
|
Stock Option (Right to Buy) |
Ernest Mario
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2015 |
1,500 |
750
|
-
|
|
-
|
Stock Option (Right to Buy) |
Ernest Mario
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2015 |
258 |
129
|
-
|
|
-
|
Stock Option (Right to Buy) |
Ernest Mario
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2015 |
3,521 |
122,773
|
-
|
|
-
|
Common Stock |
Ernest Mario
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2015 |
1,500 |
124,273
|
-
|
|
-
|
Common Stock |
Ernest Mario
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
10 Jun 2015 |
258 |
124,531
|
-
|
|
-
|
Common Stock |
Martha J. Demski
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Jun 2015 |
2,000 |
9,126
|
-
|
|
-
|
Stock Option (Right to Buy) |
Martha J. Demski
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Jun 2015 |
2,000 |
2,000
|
-
|
|
-
|
Common Stock |
Martha J. Demski
|
None |
Sale of securities on an exchange or to another person at price $ 0.00 per share. |
01 Jun 2015 |
2,000 |
0
|
-
|
|
-
|
Common Stock |
Lisa Ricciardi
|
None |
Purchase of securities on an exchange or from another person at price $ 0.00 per share. |
12 May 2015 |
1,950 |
1,950
|
-
|
|
-
|
Common Stock |
Martha J. Demski
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 May 2015 |
2,000 |
11,126
|
-
|
|
-
|
Stock Option (Right to Buy) |
Martha J. Demski
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 May 2015 |
2,000 |
2,000
|
-
|
|
-
|
Common Stock |
Martha J. Demski
|
None |
Sale of securities on an exchange or to another person at price $ 0.00 per share. |
01 May 2015 |
2,000 |
0
|
-
|
|
-
|
Common Stock |
Ernest Mario
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
06 Apr 2015 |
1,761 |
38,732
|
-
|
|
-
|
Stock Option (Right to Buy) |
Ernest Mario
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
06 Apr 2015 |
750 |
2,250
|
-
|
|
-
|
Stock Option (Right to Buy) |
Ernest Mario
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
06 Apr 2015 |
130 |
387
|
-
|
|
-
|
Stock Option (Right to Buy) |
Ernest Mario
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
06 Apr 2015 |
1,761 |
118,372
|
-
|
|
-
|
Common Stock |
Ernest Mario
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
06 Apr 2015 |
750 |
119,122
|
-
|
|
-
|
Common Stock |
Ernest Mario
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
06 Apr 2015 |
130 |
119,252
|
-
|
|
-
|
Common Stock |
Martha J. Demski
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2015 |
2,000 |
13,126
|
-
|
|
-
|
Stock Option (Right to Buy) |
Martha J. Demski
|
None |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Apr 2015 |
2,000 |
2,000
|
-
|
|
-
|
Common Stock |
Martha J. Demski
|
None |
Sale of securities on an exchange or to another person at price $ 0.00 per share. |
01 Apr 2015 |
1,700 |
300
|
-
|
|
-
|
Common Stock |
Martha J. Demski
|
None |
Sale of securities on an exchange or to another person at price $ 0.00 per share. |
01 Apr 2015 |
300 |
0
|
-
|
|
-
|
Common Stock |
Michael D. Rogers
|
Chief Development Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
23 Mar 2015 |
6,372 |
79,219
|
-
|
|
-
|
Stock Option (Right to Buy) |